Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10000454HBVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS10024515HBVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS10030586HBVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS10053076HBVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS30087144HIVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS30065198HIVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS30065199HIVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS20019502HPVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS20045985HPVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS20060442HPVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TCGA Plot Options
Drug Information
GeneHCRTR2
DrugBank IDDB15031
Drug NameDaridorexant
Target IDBE0005865
UniProt IDO43614
Regulation Typeantagonist
PubMed IDs34415378
CitationsRoch C, Bergamini G, Steiner MA, Clozel M: Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology (Berl). 2021 Oct;238(10):2693-2708. doi: 10.1007/s00213-021-05954-0. Epub 2021 Aug 20.
GroupsApproved
Direct Classification
SMILESCOC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1
Pathways
PharmGKB
ChEMBLCHEMBL4297590